Zoetis Revenue 2012-2025 | ZTS

Zoetis annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Zoetis revenue for the quarter ending September 30, 2025 was $2.400B, a 0.5% increase year-over-year.
Zoetis revenue for the twelve months ending September 30, 2025 was $9.397B, a 2.68% increase year-over-year.
Zoetis annual revenue for 2024 was $9.256B, a 8.33% increase from 2023.
Zoetis annual revenue for 2023 was $8.544B, a 5.74% increase from 2022.
Zoetis annual revenue for 2022 was $8.08B, a 3.91% increase from 2021.

Zoetis Annual Revenue (Millions of US $)
2024	$9,256
2023	$8,544
2022	$8,080
2021	$7,776
2020	$6,675
2019	$6,260
2018	$5,825
2017	$5,307
2016	$4,888
2015	$4,765
2014	$4,785
2013	$4,561
2012	$4,336
2011	$4,233

Zoetis Quarterly Revenue (Millions of US $)
2025-09-30	$2,400
2025-06-30	$2,460
2025-03-31	$2,220
2024-12-31	$2,317
2024-09-30	$2,388
2024-06-30	$2,361
2024-03-31	$2,190
2023-12-31	$2,213
2023-09-30	$2,151
2023-06-30	$2,180
2023-03-31	$2,000
2022-12-31	$2,040
2022-09-30	$2,002
2022-06-30	$2,052
2022-03-31	$1,986
2021-12-31	$1,967
2021-09-30	$1,990
2021-06-30	$1,948
2021-03-31	$1,871
2020-12-31	$1,807
2020-09-30	$1,786
2020-06-30	$1,548
2020-03-31	$1,534
2019-12-31	$1,674
2019-09-30	$1,584
2019-06-30	$1,547
2019-03-31	$1,455
2018-12-31	$1,564
2018-09-30	$1,480
2018-06-30	$1,415
2018-03-31	$1,366
2017-12-31	$1,460
2017-09-30	$1,347
2017-06-30	$1,269
2017-03-31	$1,231
2016-12-31	$1,277
2016-09-30	$1,241
2016-06-30	$1,208
2016-03-31	$1,162
2015-12-31	$1,274
2015-09-30	$1,214
2015-06-30	$1,175
2015-03-31	$1,102
2014-12-31	$1,320
2014-09-30	$1,210
2014-06-30	$1,158
2014-03-31	$1,097
2013-12-31	$1,254
2013-09-30	$1,103
2013-06-30	$1,114
2013-03-31	$1,090
2012-12-31	$1,176
2012-09-30	$1,019
2012-06-30	$1,094
2012-03-31	$1,047
2011-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$54.919B	$9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.245B	33.14
Takeda Pharmaceutical (TAK)	Japan	$50.943B	10.40
Daiichi Sankyo, - (DSNKY)	Japan	$42.301B	21.07
BeOne Medicines - (ONC)	Switzerland	$38.498B	204.10
Sandoz Group AG (SDZNY)	Switzerland	$32.476B	0.00
United Therapeutics (UTHR)	United States	$20.532B	18.07
Merck (MKKGY)	Germany	$19.360B	11.94
Shionogi (SGIOY)	Japan	$15.432B	14.17
Neurocrine Biosciences (NBIX)	United States	$13.187B	31.64
Summit Therapeutics (SMMT)	United States	$12.963B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.874B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.217B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.586B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.178B	34.58
Grifols, S.A (GRFS)	Spain	$6.078B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$5.154B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.251B	17.35
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.077B	19.36
Corcept Therapeutics (CORT)	United States	$3.824B	41.31
NewAmsterdam Pharma (NAMS)	Netherlands	$3.613B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.987B	0.00
Hypermarcas (HYPMY)	Brazil	$2.784B	19.11
Catalyst Pharmaceuticals (CPRX)	United States	$2.747B	8.76
Dyne Therapeutics (DYN)	United States	$2.434B	0.00
Soleno Therapeutics (SLNO)	United States	$2.230B	0.00
Ocular Therapeutix (OCUL)	United States	$2.222B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.979B	38.12
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.976B	23.42
Harrow (HROW)	United States	$1.748B	107.25
Ardelyx (ARDX)	United States	$1.711B	0.00
Enliven Therapeutics (ELVN)	United States	$1.528B	0.00
Oruka Therapeutics (ORKA)	United States	$1.517B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.495B	7.40
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Amylyx Pharmaceuticals (AMLX)	United States	$1.384B	0.00
Relay Therapeutics (RLAY)	United States	$1.376B	0.00
Evotec AG (EVO)	Germany	$1.374B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.279B	0.00
Savara (SVRA)	United States	$1.205B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.118B	0.00
Cronos Group (CRON)	Canada	$1.032B	0.00
Theravance Biopharma (TBPH)	United States	$1.030B	43.26
Xencor (XNCR)	United States	$0.995B	0.00
Esperion Therapeutics (ESPR)	United States	$0.789B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.755B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.755B	17.85
Nektar Therapeutics (NKTR)	United States	$0.744B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.689B	6.15
ProKidney (PROK)	United States	$0.689B	0.00
Bioventus (BVS)	United States	$0.637B	13.05
Lexeo Therapeutics (LXEO)	United States	$0.542B	0.00
Organogenesis (ORGO)	United States	$0.518B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.516B	0.00
Lyell Immunopharma (LYEL)	United States	$0.504B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.502B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.47
4D Molecular Therapeutics (FDMT)	United States	$0.449B	0.00
Altimmune (ALT)	United States	$0.418B	0.00
Aquestive Therapeutics (AQST)	United States	$0.417B	0.00
Nature's Sunshine Products (NATR)	United States	$0.392B	23.34
USANA Health Sciences (USNA)	United States	$0.371B	10.36
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.318B	0.00
Profound Medical (PROF)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.294B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.271B	0.00
Protara Therapeutics (TARA)	United States	$0.254B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.249B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.198B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.190B	0.00
Century Therapeutics (IPSC)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.185B	0.00
MediWound (MDWD)	Israel	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.177B	0.00
AleAnna (ANNA)	United States	$0.168B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.145B	0.00
Prelude Therapeutics (PRLD)	United States	$0.141B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.139B	0.00
Context Therapeutics (CNTX)	United States	$0.138B	0.00
Incannex Healthcare (IXHL)	Australia	$0.132B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.130B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
VAXART, INC (VXRT)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Pyxis Oncology (PYXS)	United States	$0.117B	0.00
Avita Medical (RCEL)	United States	$0.101B	0.00
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.50
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Gain Therapeutics (GANX)	United States	$0.086B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.50
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Plus Therapeutics (PSTV)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.065B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.055B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
ElectroCore (ECOR)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.038B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.018B	0.00
Cosmos Health (COSM)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.013B	0.02
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.012B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00